1. Home
  2. BTBT vs NTLA Comparison

BTBT vs NTLA Comparison

Compare BTBT & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BTBT
  • NTLA
  • Stock Information
  • Founded
  • BTBT 2015
  • NTLA 2014
  • Country
  • BTBT United States
  • NTLA United States
  • Employees
  • BTBT N/A
  • NTLA N/A
  • Industry
  • BTBT Finance: Consumer Services
  • NTLA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • BTBT Finance
  • NTLA Health Care
  • Exchange
  • BTBT Nasdaq
  • NTLA Nasdaq
  • Market Cap
  • BTBT 1.1B
  • NTLA 1.2B
  • IPO Year
  • BTBT 2018
  • NTLA 2016
  • Fundamental
  • Price
  • BTBT $2.99
  • NTLA $10.79
  • Analyst Decision
  • BTBT Strong Buy
  • NTLA Buy
  • Analyst Count
  • BTBT 3
  • NTLA 20
  • Target Price
  • BTBT $6.33
  • NTLA $32.70
  • AVG Volume (30 Days)
  • BTBT 46.6M
  • NTLA 4.6M
  • Earning Date
  • BTBT 08-18-2025
  • NTLA 08-07-2025
  • Dividend Yield
  • BTBT N/A
  • NTLA N/A
  • EPS Growth
  • BTBT N/A
  • NTLA N/A
  • EPS
  • BTBT N/A
  • NTLA N/A
  • Revenue
  • BTBT $102,037,923.00
  • NTLA $52,857,000.00
  • Revenue This Year
  • BTBT $20.87
  • NTLA N/A
  • Revenue Next Year
  • BTBT $38.28
  • NTLA N/A
  • P/E Ratio
  • BTBT N/A
  • NTLA N/A
  • Revenue Growth
  • BTBT 52.44
  • NTLA 14.99
  • 52 Week Low
  • BTBT $1.69
  • NTLA $5.90
  • 52 Week High
  • BTBT $5.74
  • NTLA $24.16
  • Technical
  • Relative Strength Index (RSI)
  • BTBT 48.44
  • NTLA 43.74
  • Support Level
  • BTBT $2.66
  • NTLA $11.17
  • Resistance Level
  • BTBT $3.64
  • NTLA $11.54
  • Average True Range (ATR)
  • BTBT 0.28
  • NTLA 0.84
  • MACD
  • BTBT -0.04
  • NTLA -0.32
  • Stochastic Oscillator
  • BTBT 33.67
  • NTLA 5.45

About BTBT Bit Digital Inc.

Bit Digital Inc is engaged in the Bitcoin mining business, Ethereum staking activities and specialized cloud-infrastructure services for artificial intelligence applications through its wholly owned subsidiaries. Its mining platform operates with the primary intent of accumulating bitcoin which may sell for fiat currency from time to time depending on market conditions. The Company has four reportable segments: digital asset mining, cloud services, colocation services, and ETH Staking. It generates majority of its revenue from digital asset mining.

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Share on Social Networks: